Biocardia Inc. buy me8
Start price
14.12.20
/
50%
€4.53
Target price
14.12.21
€5.00
Performance (%)
-24.50%
End price
29.01.21
€3.42
Summary
This prediction ended on 29.01.21 with a price of €3.42. The price of Biocardia Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -24.50%. me8 has a follow-up prediction for Biocardia Inc. where he still thinks Biocardia Inc. is a Buy. me8 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biocardia Inc. | - | - | - | - |
| iShares Core DAX® | 4.015% | 2.971% | 16.492% | 19.144% |
| iShares Nasdaq 100 | 2.755% | 0.503% | 40.029% | 50.636% |
| iShares Nikkei 225® | -0.826% | -5.057% | 14.566% | 2.379% |
| iShares S&P 500 | 2.330% | 0.720% | 30.194% | 44.181% |
According to me8 what are the pros and cons of Biocardia Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Capable Management
Differentiated customer and product portfolio
Cons
high free float
Comments by me8 for this prediction
In the thread Biocardia Inc. diskutieren
In the thread Trading Biocardia Inc.
Current prediction by me8 for Biocardia Inc.
Biocardia Inc.
Start price
Target price
Perf. (%)
€0.81
15.11.23
15.11.23
-
15.11.24
15.11.24
-56.52%
09.05.24
09.05.24
Could be worthwhile Investment >10% per year
Capable Management
Differentiated customer and product portfolio
high free float
